Buy DOCS by May 23, 2025.

It’s the largest digital platform for U.S. medical pros, with over 80% of physicians using it, creating a killer network effect that attracts big pharma and hospitals. Revenue’s growing fast—up 20.4% in the latest quarter, with a 33.7% profit margin—and it’s diversified into telehealth, CME, and productivity tools like HIPAA-secure faxes. Founder-led with strong leadership, it’s riding the digital health wave, and recent X posts show its stock surging. But beware: it’s pricey (P/E of 59.7), relies on doc engagement, …